MILWAUKIE, Ore., March 27, 2013—Senator Tom Harkin (D-Iowa) was honored recently by the American Association of Homeopathic Pharmacists (AAHP) with an award of appreciation for introducing and supporting legislation that safeguards Americans’ right to choose complementary health care. Chairman of the Senate Health, Education, Labor and Pensions Committee, Senator Harkin is a longtime supporter of patient access to homeopathic medicines.
Mark Land, president of AAHP, said, “We value the Senator’s passion for improving people’s health and holding down health care costs through healthier living. The AAHP and its members deeply appreciate the Senator’s support of homeopathic medicines as a health care choice.”
Homeopathic medicines provide relatively low-cost, non-prescription options for self-treatable conditions in the marketplace. They have an extraordinary record of safety for any class of drugs, which encourages a proactive health approach at the first sign of symptom. More than 200 years of successful medical use throughout the world has provided a strong basis of proof for the safety and usefulness of homeopathic medicines, resulting in this therapy being a growing choice among patients and health care professionals alike.
In a March 4th letter congratulating the members of AAHP on their 90th anniversary, Senator Harkin recognized the importance of AAHP’s mission “to promote responsible industry practices for regulatory compliance, strengthen ingredient product quality, and ensure truthful and compliant product labeling and consumer safety through education outreach.”
“Throughout my career in Congress, I have been pleased to work closely with AAHP representatives to ensure that my constituents and all Americans continue to enjoy access to a wide range of personalized homeopathic medicines,” wrote Senator Harkin.
Senator Harkin received the plaque from AAHP, the first of its kind presented by the not-for-profit organization, during his visit to the Natural Products Expo West at the Anaheim Convention Center in Calif. on March 8.
About Boiron: Boiron, world leader in homeopathic medicines, is a $852 million public company with 3,700 employees and distribution in 59 countries. It is best known for Oscillococcinum®, a top-selling flu medicine, and its Arnicare® line of pain relievers. For more than 80 years, Boiron has been committed to funding scientific research and educating the public and healthcare professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.